Monitoring, characterization and control of chronic, symptomatic malaria infections in rural Zambia through monthly household visits by paid community health workers

Malaria Journal

Volumn 13, Issue 1, 2014, Pages

  Hamainza, Busiku ^a,b   Moonga, Hawela ^a   Sikaala, Chadwick H ^a,b   Kamuliwo, Mulakwa ^a   Bennett, Adam ^c   Eisele, Thomas P ^c   Miller, John ^d   Seyoum, Aklilu ^b   Killeen, Gerry F ^b,c,e  

^a MINISTRY OF HEALTH   (Zambia)

^b LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^c TULANE UNIVERSITY   (United States)

^d Chainama Hills College Hospital   (Zambia)

^e IFAKARA HEALTH INSTITUTE   (Tanzania)

Author keywords

Community health worker; Malaria; Passive and active case detection; Rapid diagnostic tests; Surveillance; Treatment with ACT

Indexed keywords

ARTEMETHER PLUS BENFLUMETOL; PYRIMETHAMINE PLUS SULFADOXINE;

ARTICLE; BED NET; COST EFFECTIVENESS ANALYSIS; COUGHING; DIARRHEA; FEVER; HEADACHE; HEALTH AUXILIARY; HEALTH CARE COST; HEALTH CARE FACILITY; HUMAN; MAJOR CLINICAL STUDY; MALARIA; MALARIA CONTROL; MICROSCOPY; PRACTICE GUIDELINE; PROFESSIONAL PRACTICE; REMUNERATION; RURAL AREA; SYMPTOM; THORAX PAIN; VECTOR CONTROL; VOMITING; ZAMBIA;

COMMUNITY HEALTH WORKERS; DELIVERY OF HEALTH CARE; DIAGNOSTIC TESTS, ROUTINE; INCIDENCE; MALARIA; MASS SCREENING; PLASMODIUM FALCIPARUM; PREVALENCE; RURAL POPULATION; TIME FACTORS; ZAMBIA;

EID: 84898838247     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-13-128     Document Type: Article

References (108)

1. High prevalence of asymptomatic Plasmodium vivax and Plasmodium falciparum infections in native Amazonian populations. Alves FP, Durlacher RR, Menezes MJ, Krieger H, Silva LH, Camargo EP, Am J Trop Med Hyg 2002 66 641 648 12224567 (Pubitemid 35001032)
2. Malaria: even more chronic in nature than previously thought; evidence for subpatent parasitaemia detectable by the polymerase chain reaction. Bottius E, Guanzirolli A, Trape JF, Rogier C, Konate L, Druilhe P, Trans R Soc Trop Med Hyg 1996 90 15 19 10.1016/S0035-9203(96)90463-0 8730301 (Pubitemid 26069436)
3. Attributable fraction estimates and case definitions for malaria in endemic areas. Smith T, Schellenberg JA, Hayes R, Stat Med 1994 13 2345 2358 10.1002/sim.4780132206 7855468 (Pubitemid 24354857)
4. Characteristics of Plasmodium falciparum parasites that survive the lengthy dry season in eastern Sudan where malaria transmission is markedly seasonal. Babiker HA, Abdel-Muhsin AM, Ranford-Cartwright LC, Satti G, Walliker D, Am J Trop Med Hyg 1998 59 582 590 9790434 (Pubitemid 28480715)
5. Plasmodium falciparum gametocyte carriage in asymptomatic children in western Kenya. Bousema JT, Gouagna LC, Drakeley CJ, Meutstege AM, Okech BA, Akim IN, Beier JC, Githure JI, Sauerwein RW, Malar J 2004 3 18 10.1186/1475-2875-3- 18 15202944 (Pubitemid 39319755)
6. The role of chemotherapy in malaria control through primary health care: constraints and future prospects. Jeffery GM, Bull World Health Organ 1984 62 49 53 6335682 (Pubitemid 15165245)
7. A second chance to tackle african malaria vector mosquitoes that avoid houses and don't take drugs. Killeen GF, Am J Trop Med Hyg 2013 88 809 816 10.4269/ajtmh.13-0065 23589532
8. Molineaux L, Gramiccia G, The Garki project: research on the epidemiology and control of malaria in the Sudan savanna of West Africa Geneva,Switzerland: World Health Organization 1980
9. Chloroquine-resistant malaria. Wellems TE, Plowe CV, J Infect Dis 2001 184 770 776 10.1086/322858 11517439 (Pubitemid 32826429)
10. Drug resistance in malaria. Parija SC, Praharaj I, Indian J Med Microbiol 2011 29 243 248 10.4103/0255-0857.83906 21860103
11. Kouznetsov R, Antimalarial Drug Requirements For National Malaria Control Programmes In Developing Countries, 1982-1989, Second Report Geneva, Switzerland: World Health Organization 1987
12. The biological and epidemiological basis of drug resistance in malaria parasites. Wernsdorfer WH, Southeast Asian J Trop Med Public Health 1992 23 Suppl 4 123 129 1364857
13. WHO, Consideration Of Mass Drug Administration For The Containment Of Artemisinin-Resistant Malaria In The Greater Mekong Subregion Geneva, Switzerland: World Health Organization, Heseltine E, Report of a consensus meeting. 2010
14. Optimising strategies for Plasmodium falciparum malaria elimination in Cambodia: primaquine, mass drug administration and artemisinin resistance. Maude RJ, Socheat D, Nguon C, Saroth P, Dara P, Li G, Song J, Yeung S, Dondorp AM, Day NP, White NJ, White LJ, PLoS One 2012 7 37166 10.1371/journal.pone.0037166 22662135
15. Operational strategies to achieve and maintain malaria elimination. Moonen B, Cohen JM, Snow RW, Slutsker L, Drakeley C, Smith DL, Abeyasinghe RR, Rodriguez MH, Maharaj R, Tanner M, Targett G, Lancet 2010 376 1592 1603 10.1016/S0140-6736(10)61269-X 21035841
16. Malaria control: achievements, problems and strategies. Najera JA, Parassitologia 2001 43 1 89 (Pubitemid 33645183)
17. Treatment-seeking behaviour for malaria: a typology based on endemicity and gender. Tanner M, Vlassoff C, Soc Sci Med 1998 46 523 532 10.1016/S0277-9536(97)00195-0 9460831 (Pubitemid 28024891)
18. Treatment seeking for malaria: a review of recent research. McCombie SC, Soc Sci Med 1996 43 933 945 10.1016/0277-9536(95)00446-7 8888463 (Pubitemid 26306536)
19. Modelling the impact of artemisinin combination therapy and long-acting treatments on malaria transmission intensity. Okell LC, Drakeley CJ, Bousema T, Whitty CJ, Ghani AC, PLoS Med 2008 5 226 discussion e226 10.1371/journal.pmed. 0050226 19067479
20. The role of antimalarial treatment in the elimination of malaria. Gosling RD, Okell L, Mosha J, Chandramohan D, Clin Microbiol Infect 2011 17 1617 1623 10.1111/j.1469-0691.2011.03660.x 21951597
21. Submicroscopic infection in Plasmodium falciparum-endemic populations: a systematic review and meta-analysis. Okell LC, Ghani AC, Lyons E, Drakeley CJ, J Infect Dis 2009 200 1509 1517 10.1086/644781 19848588
22. The effect of mass administration of sulfadoxine-pyrimethamine combined with artesunate on malaria incidence: a double-blind, community-randomized, placebo-controlled trial in The Gambia. von Seidlein L, Walraven G, Milligan PJ, Alexander N, Manneh F, Deen JL, Coleman R, Jawara M, Lindsay SW, Drakeley C, De Martin S, Olliaro P, Bennett S, Schim van der Loeff M, Okunoye K, Targett GA, McAdam KP, Doherty JF, Greenwood BM, Pinder M, Trans R Soc Trop Med Hyg 2003 97 217 225 10.1016/S0035-9203(03)90125-8 14584381 (Pubitemid 37265637)
23. Health-seeking behaviour for febrile illness in malaria-endemic Kalasib district, Mizoram, India. Lalchhuanawma R, Murhekar MV, Int Health 2012 4 314 319 10.1016/j.inhe.2012.06.003 24029679
24. Malaria treatment-seeking behaviour and related factors of Wa ethnic minority in Myanmar: a cross sectional study. Xu J-W, Xu Q-Z, Liu H, Zeng Y-R, Malar J 2012 11 417 10.1186/1475-2875-11-417 23237576
25. Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination. Bousema T, Drakeley C, Clin Microbiol Rev 2011 24 377 410 10.1128/CMR.00051-10 21482730
26. Gametocytaemia after drug treatment of asymptomatic Plasmodium falciparum. Dunyo S, Milligan P, Edwards T, Sutherland C, Targett G, Pinder M, PLoS Clin Trials 2006 1 20 10.1371/journal.pctr.0010020 17013431
27. Factors determining the occurrence of submicroscopic malaria infections and their relevance for control. Okell LC, Bousema T, Griffin JT, Ouedraogo AL, Ghani AC, Drakeley CJ, Nat Commun 2012 3 1237 23212366
28. A controlled, parallel, cluster-randomized trial of community-wide screening and treatment of asymptomatic carriers of Plasmodium falciparum in Burkina Faso. Tiono AB, Ouedraogo A, Ogutu B, Diarra A, Coulibaly S, Gansane A, Sirima SB, O'Neil G, Mukhopadhyay A, Hamed K, Malar J 2013 12 79 10.1186/1475-2875-12-79 23442748
29. Asymptomatic malaria in the etiology of iron deficiency anemia: a nutritionist's viewpoint. Prentice AM, Cox SE, Nweneka CV, Am J Clin Nutr 2010 92 1283 1284 10.3945/ajcn.110.004465 21068349
30. Relationships between the outcome of Plasmodium falciparum infection and the intensity of transmission in Africa. Smith T, Killeen G, Lengeler C, Tanner M, Am J Trop Med Hyg 2004 71 80 86 15331822 (Pubitemid 39121307)
31. Estimates of the infectious reservoir of Plasmodium falciparum malaria in The Gambia and in Tanzania. Drakeley CJ, Akim NI, Sauerwein RW, Greenwood BM, Targett GA, Trans R Soc Trop Med Hyg 2000 94 472 476 10.1016/S0035-9203(00) 90056-7 11132369
32. Malaria in the United Kingdom. Bruce-Chwatt LJ, Southgate BA, Draper CC, Br Med J 1974 2 707 711 10.1136/bmj.2.5921.707 4604717
33. WHO, The Biology Of Malaria Parasites Geneva: World Health Organization vol. 743 Technical Report Series. 1987
34. The distribution of Plasmodium falciparum infection durations. Bretscher MT, Maire N, Chitnis N, Felger I, Owusu-Agyei S, Smith T, Epidemics 2011 3 109 118 10.1016/j.epidem.2011.03.002 21624782
35. A cluster-randomized trial of mass drug administration with a gametocytocidal drug combination to interrupt malaria transmission in a low endemic area in Tanzania. Shekalaghe SA, Drakeley C, van den Bosch S, ter Braak R, van den Bijllaardt W, Mwanziva C, Semvua S, Masokoto A, Mosha F, Teelen K, Hermsen R, Okell L, Gosling R, Sauerwein R, Bousema T, Malar J 2011 10 247 10.1186/1475-2875-10-247 21864343
36. WHO, Terminology Of Malaria And Of Malaria Eradication Geneva, Switzerland: World Health Organization 1963
37. Anti-malarial drugs and the prevention of malaria in the population of malaria endemic areas. Greenwood B, Malar J 2010 9 Suppl 3 2 21144082
38. A community-directed strategy for sustainable malaria elimination on islands: short-term MDA integrated with ITNs and robust surveillance. Kaneko A, Acta Trop 2010 114 177 183 10.1016/j.actatropica.2010.01.012 20132788
39. Treatment of asymptomatic carriers with artemether-lumefantrine: an opportunity to reduce the burden of malaria? Ogutu B, Tiono A, Makanga M, Premji Z, Gbadoe A, Ubben D, Marrast A, Gaye O, Malar J 2010 9 30 10.1186/1475-2875-9- 30 20096111
40. Modelling the cost-effectiveness of mass screening and treatment for reducing Plasmodium falciparum malaria burden. Crowell V, Briet OJ, Hardy D, Chitnis N, Maire N, Di Pasquale A, Smith TA, Malar J 2013 12 4 10.1186/1475-2875-12-4 23286228
41. Improving community health worker use of malaria rapid diagnostic tests in Zambia: package instructions, job aid and job aid-plus-training. Harvey SA, Jennings L, Chinyama M, Masaninga F, Mulholland K, Bell DR, Malar J 2008 7 160 10.1186/1475-2875-7-160 18718028
42. Community health workers use malaria rapid diagnostic tests (RDTs) safely and accurately: results of a longitudinal study in Zambia. Counihan H, Harvey SA, Sekeseke-Chinyama M, Hamainza B, Banda R, Malambo T, Masaninga F, Bell D, Am J Trop Med Hyg 2012 87 57 63 10.4269/ajtmh.2012.11-0800 22764292
43. WHO, The Roll Back Malaria Strategy For Improving Access To Treatment Through Home Management Of Malaria Geneva, Switzerland: World Health Organization 2005
44. WHO, Community-Based Reduction Of Malaria Transmission Geneva, Switzerland: World Health Organization, Heseltine E, Informal consultatIon organized by the WHO global malarIa Programme in collaboratIon wIth malarIa eradIcatIon research agenda (malERA) initiative. 2012
45. Use and limitations of malaria rapid diagnostic testing by community health workers in war-torn Democratic Republic of Congo. Hawkes M, Katsuva JP, Masumbuko CK, Malar J 2009 8 308 10.1186/1475-2875-8-308 20028563
46. Community case management of malaria using ACT and RDT in two districts in Zambia: achieving high adherence to test results using community health workers. Chanda P, Hamainza B, Moonga HB, Chalwe V, Pagnoni F, Malar J 2011 10 158 10.1186/1475-2875-10-158 21651827
47. Relative costs and effectiveness of treating uncomplicated malaria in two rural districts in Zambia: implications for nationwide scale-up of home-based management. Chanda P, Hamainza B, Moonga HB, Chalwe V, Banda P, Pagnoni F, Malar J 2011 10 159 10.1186/1475-2875-10-159 21651828
48. Economic advantage of a community-based malaria management program in the Brazilian Amazon. Pang LW, Piovesan-Alves F, Am J Trop Med Hyg 2001 65 883 886 11791992 (Pubitemid 34049490)
49. Access to artemisinin combination therapy for malaria in remote areas of Cambodia. Yeung S, Van Damme W, Socheat D, White NJ, Mills A, Malar J 2008 7 96 10.1186/1475-2875-7-96 18510724 (Pubitemid 351990315)
50. Feasibility and acceptability of home-based management of malaria strategy adapted to Sudan's conditions using artemisinin-based combination therapy and rapid diagnostic test. Elmardi KA, Malik EM, Abdelgadir T, Ali SH, Elsyed AH, Mudather MA, Elhassan AH, Adam I, Malar J 2009 8 39 10.1186/1475-2875-8-39 19272157
51. Quality and safety of integrated community case management of malaria using rapid diagnostic tests and pneumonia by community health workers. Hamer DH, Brooks ET, Semrau K, Pilingana P, MacLeod WB, Siazeele K, Sabin LL, Thea DM, Yeboah-Antwi K, Pathog Glob Health 2012 106 32 39 10.1179/1364859411Y. 0000000042 22595272
52. Community acceptability of use of rapid diagnostic tests for malaria by community health workers in Uganda. Mukanga D, Tibenderana JK, Kiguli J, Pariyo GW, Waiswa P, Bajunirwe F, Mutamba B, Counihan H, Ojiambo G, Källander K, Malar J 2010 9 203 10.1186/1475-2875-9-203 20626863
53. A qualitative study of the feasibility and community perception on the effectiveness of artemether-lumefantrine use in the context of home management of malaria in south-west Nigeria. Ajayi IO, Falade CO, Olley BO, Yusuf B, Gbotosho S, Iyiola T, Olaniyan O, Happi C, Munguti K, Pagnoni F, BMC Health Serv Res 2008 8 119 10.1186/1472-6963-8-119 18513447
54. Community case management of fever due to malaria and pneumonia in children under five in Zambia: a cluster randomized controlled trial. Yeboah-Antwi K, Pilingana P, Macleod WB, Semrau K, Siazeele K, Kalesha P, Hamainza B, Seidenberg P, Mazimba A, Sabin L, Kamholz K, Thea DM, Hamer DH, PLoS Med 2010 7 1000340 10.1371/journal.pmed.1000340 20877714
55. Using community-owned resource persons to provide early diagnosis and treatment and estimate malaria burden at community level in north-eastern Tanzania. Rutta AS, Francis F, Mmbando B, Ishengoma D, Sembuche S, Malecela E, Sadi J, Kamugisha M, Lemnge M, Malar J 2012 11 152 10.1186/1475-2875-11-152 22554149
56. WHO, World Malaria Report Geneva, Switzerland: World Health Organization 2012 2013
57. Evaluation of alternative mosquito sampling methods for malaria vectors in Lowland South-East Zambia. Sikaala CH, Killeen GF, Chanda J, Chinula D, Miller JM, Russell TL, Seyoum A, Parasit Vectors 2013 6 91 10.1186/1756-3305-6- 91 23570257
58. Human exposure to anopheline mosquitoes occurs primarily indoors, even for users of insecticide-treated nets in Luangwa Valley, South-east Zambia. Seyoum A, Sikaala CH, Chanda J, Chinula D, Ntamatungiro AJ, Hawela M, Miller JM, Russell TL, Briet OJ, Killeen GF, Parasit Vectors 2012 5 101 10.1186/1756-3305-5-101 22647493
59. Kasali G, Climate Change and Health in Zambia Lusaka, Zambia: CLACC Working Paper 2-Capacity Strengthening in the Least Developed Countries for Adaptation to Climate Change: International Institute for Environment and Development 2008
60. Ministry of Health, Integrated Management of Childhood Illness, Caring for Newborns and Children in the Community-A Manual for the Community Health Worker Lusaka, Zambia: Ministry of Health 2010
61. Central Statistical Office, 2010 Census Of Population And Housing-Zambia Preliminary Population Figures Lusaka, Zambia: Central Statistical Office 2011
62. Malaria infection and anemia prevalence in Zambia's Luangwa District: an area of near-universal insecticide-treated mosquito net coverage. Eisele TP, Miller JM, Moonga HB, Hamainza B, Hutchinson P, Keating J, Am J Trop Med Hyg 2011 84 152 157 10.4269/ajtmh.2011.10-0287 21212219
63. A quasi-experimental evaluation of an interpersonal communication intervention to increase insecticide-treated net use among children in Zambia. Keating J, Hutchinson P, Miller JM, Bennett A, Larsen DA, Hamainza B, Changufu C, Shiliya N, Eisele TP, Malar J 2012 11 313 10.1186/1475-2875-11-313 22958441
64. Centre NMC, Action Plan Lusaka Zambia: National Malaria Control Centre, Ministry of Health 2011
65. National Malaria Control Centre, Action Plan Lusaka, Zambia: National Malaria Control Centre, Ministry of Health 2012
66. National Malaria Control Centre, Zambia Malaria Rapid Reporting System User Manual Lusaka, Zambia: National Malaria Control Centre, Ministry of Health 2011
67. The principle of parsimony. Sober E, Br J Philos Sci 1981 32 145 156 10.1093/bjps/32.2.145
68. Cost-effectiveness analysis of rapid diagnostic test, microscopy and syndromic approach in the diagnosis of malaria in Nigeria: implications for scaling-up deployment of ACT. Uzochukwu BS, Obikeze EN, Onwujekwe OE, Onoka CA, Griffiths UK, Malar J 2009 8 265 10.1186/1475-2875-8-265 19930666
69. United States Agenct for International Developmen, Price Analysis Of Malaria Rapid Diagnostic Test Kits Arlington, United States of America: USAID Deliver Project, U.S. Agency for International Development 2012
70. Asymptomatic carriage of Plasmodium in urban Dakar: the risk of malaria should not be underestimated. Diallo A, Nadam N, Moussiliou A, Dos Santos S, Ndonky A, Borderon M, Oliveau S, Lalou R, le Hesran J, PLoS One 2012 7 31100 10.1371/journal.pone.0031100 22363558
71. Ministry of Health, National Malaria Indicator Survey Lusaka, Zambia: National Malaria Control Centre, Ministry of Health 2010
72. Ministry of Health, National Malaria Indicator Survey Lusaka, Zambia: National Malaria Control Centre, Ministry of Health 2012
73. Endemicity response timelines for Plasmodium falciparum elimination. Smith DL, Hay SI, Malar J 2009 8 87 10.1186/1475-2875-8-87 19405974
74. Monitoring fever treatment behaviour and equitable access to effective medicines in the context of initiatives to improve ACT access: baseline results and implications for programming in six African countries. Littrell M, Gatakaa H, Evance I, Poyer S, Njogu J, Solomon T, Munroe E, Chapman S, Goodman C, Hanson K, Zinsou C, Akulayi L, Raharinjatovo J, Arogundade E, Buyungo P, Mpasela F, Adjibabi CB, Agbango JA, Ramarosandratana BF, Coker B, Rubahika D, Hamainza B, Shewchuk T, Chavasse D, O'Connell KA, Malar J 2011 10 327 10.1186/1475-2875-10- 327 22039892
75. A community-based programme to provide prompt and adequate treatment of presumptive malaria in children. Pagnoni F, Convelbo N, Tiendrebeogo J, Cousens S, Esposito F, Trans R Soc Trop Med Hyg 1997 91 512 517 10.1016/S0035-9203(97) 90006-7 9463653 (Pubitemid 27478632)
76. Rapid decrease of malaria morbidity following the introduction of community-based monitoring in a rural area of central Vietnam. Thang ND, Erhart A, Hung le X, Thuan le K, Xa NX, Thanh NN, Ky PV, Coosemans M, Speybroeck N, D'Alessandro U, Malar J 2009 8 3 10.1186/1475-2875-8-3 19123932
77. WHO, Malaria Elimination: A field Manual For Low And Moderate Endemic Countries Geneva: World Health Organization 2007
78. World Health Organization, Guidelines On The Elimination Of Residual Foci Of Malaria Transmission Cairo, Egypt: WHO Regional Office for the Eastern Mediterranean EMRO Technical Publications. 2007
79. Comparison of asymptomatic Plasmodium spp. infection in two malaria-endemic Colombian locations. Cucunuba Z, Guerra A, Rivera J, Nicholls R, Trans R Soc Trop Med Hyg 2013 107 129 136 10.1093/trstmh/trs021 23222954
80. The silent threat: asymptomatic parasitemia and malaria transmission. Lindblade KA, Steinhardt L, Samuels A, Kachur S, Slutsker L, Expert Rev Anti Infect Ther 2013 11 623 639 10.1586/eri.13.45 23750733
81. Bisoffi Z, Gobbi F, Buonfrate D, Van den Ende J, Diagnosis Of Malaria Infection With Or Without Disease Infect Dis: Mediterr J Hematol 2012 4
82. Submicroscopic Plasmodium falciparum gametocyte densities frequently result in mosquito infection. Schneider P, Bousema JT, Gouagna LC, Otieno S, van de Vegte-Bolmer M, Omar SA, Sauerwein RW, Am J Trop Med Hyg 2007 76 470 474 17360869 (Pubitemid 351627738)
83. Targeting asymptomatic malaria infections: active surveillance in control and elimination. Sturrock H, Hsiang M, Cohen J, Smith D, Greenhouse B, Bousema J, Gosling R, PLoS Med 2013 10 1001467 10.1371/journal.pmed.1001467 23853551
84. Malaria in Africa can be eliminated. Campbell CC, Steketee RW, Am J Trop Med Hyg 2011 85 584 585 10.4269/ajtmh.2011.11-0529 21976554
85. The activities of current antimalarial drugs on the life cycle stages of Plasmodium: a comparative study with human and rodent parasites. Delves M, Plouffe D, Scheurer C, Meister S, Wittlin S, Winzeler EA, Sinden RE, Leroy D, PLoS Med 2012 9 1001169 10.1371/journal.pmed.1001169 22363211
86. Classification of antimalarial drugs in relation to different stages in the life-cycle of the parasite: commentary on a diagram. Bruce-Chwatt LJ, Bull World Health Organ 1962 27 287 290 14016124
87. Reduction of malaria transmission to Anopheles mosquitoes with a six-dose regimen of co-artemether. Sutherland CJ, Ord R, Dunyo S, Jawara M, Drakeley CJ, Alexander N, Coleman R, Pinder M, Walraven G, Targett GA, PLoS Med 2005 2 92 10.1371/journal.pmed.0020092 15839740 (Pubitemid 40721079)
88. Addition of artesunate to chloroquine for treatment of Plasmodium falciparum malaria in Gambian children causes a significant but short-lived reduction in infectiousness for mosquitoes. Drakeley CJ, Jawara M, Targett GA, Walraven G, Obisike U, Coleman R, Pinder M, Sutherland CJ, Trop Med Int Health 2004 9 53 61 10.1046/j.1365-3156.2003.01169.x 14728607 (Pubitemid 38178012)
89. Moderate effect of artemisinin-based combination therapy on transmission of Plasmodium falciparum. Bousema JT, Schneider P, Gouagna LC, Drakeley CJ, Tostmann A, Houben R, Githure JI, Ord R, Sutherland CJ, Omar SA, Sauerwein RW, J Infect Dis 2006 193 1151 1159 10.1086/503051 16544256
90. A malaria model tested in the African savannah. Dietz K, Molineaux L, Thomas A, Bull World Health Organ 1974 50 347 357 4613512
91. Insecticide resistance and the future of malaria control in Zambia. Chanda E, Hemingway J, Kleinschmidt I, Rehman A, Ramdeen V, Phiri F, Coetzer S, Mthembu D, Shinondo C, Chizema-Kawesha E, PLoS One 2011 6 24336 10.1371/journal.pone.0024336 21915314
92. A quantitative analysis of transmission efficiency versus intensity for malaria. Smith D, Drakeley C, Chiyaka C, Hay S, Nat Commun 2010 1 108 10.1038/ncomms1107 21045826
93. Rapid diagnostic tests for diagnosing uncomplicated P. falciparum malaria in endemic countries. Abba K, Deeks JJ, Olliaro P, Naing CM, Jackson SM, Takwoingi Y, Donegan S, Garner P, Cochrane Database Syst Rev 2011 (7) D008122
94. Accuracy of a rapid diagnostic test on the diagnosis of malaria infection and of malaria-attributable fever during low and high transmission season in Burkina Faso. Bisoffi Z, Sirima S, Menten J, Pattaro C, Angheben A, Gobbi F, Tinto H, Lodesani C, Neya B, Gobbo M, Van den Ende J, Malar J 2010 9 192 10.1186/1475-2875-9-192 20609211
95. The entomological inoculation rate and Plasmodium falciparum infection in African children. Smith DL, Dushoff J, Snow RW, Hay SI, Nature 2005 438 492 495 10.1038/nature04024 16306991 (Pubitemid 41742019)
96. Relationship between the entomologic inoculation rate and the force of infection for Plasmodium falciparum malaria. Smith T, Maire N, Dietz K, Killeen GF, Vounatsou P, Molineaux L, Tanner M, Am J Trop Med Hyg 2006 75 11 18 16931811
97. Incidence of Plasmodium falciparum infection in infants in relation to exposure to sporozoite-infected anophelines. Charlwood JD, Smith T, Lyimo E, Kitua AY, Masanja H, Booth M, Alonso PL, Tanner M, Am J Trop Med Hyg 1998 59 243 251 9715940 (Pubitemid 28418982)
98. Short report: entomologic inoculation rates and Plasmodium falciparum malaria prevalence in Africa. Beier JC, Killeen GF, Githure JI, Am J Trop Med Hyg 1999 61 109 113 10432066 (Pubitemid 29344998)
99. Variation of sensitivity, specificity, likelihood ratios and predictive values with disease prevalence. Brenner H, Gefeller O, Stat Med 1997 16 981 991 10.1002/(SICI)1097-0258(19970515)16:9<981::AID-SIM510>3.0.CO;2-N 9160493 (Pubitemid 27198986)
100. Uncommon asymptomatic Plasmodium falciparum infections in Gabonese children. Missinou M, Lell B, Kremsner P, Clin Infect Dis 2003 36 1198 1202 10.1086/374555 12715318 (Pubitemid 36549645)
101. Genesis, sequestration and survival of Plasmodium falciparum gametocytes: parameter estimates from fitting a model to malariatherapy data. Eichner M, Diebner H, Molineaux L, Collins W, Jeffery G, Dietz K, Trans R Soc Trop Med Hyg 2001 95 497 501 10.1016/S0035-9203(01)90016-1 11706658 (Pubitemid 34947403)
102. A retrospective examination of sporozoite- and trophozoite-induced infections with Plasmodium falciparum: development of parasitologic and clinical immunity during primary infection. Collins W, Jeffery G, Am J Trop Med Hyg 1999 61 4 19 10.4269/tropmed.1999.61-04 10432041
103. National Malaria Control Centre, Assessment of patient compliance to artemether-lumefantrine in Zambia Lusaka, Zambia: National Malaria Control Centre, Ministry of Health 2006
104. Paracheck-Pf accuracy and recently treated Plasmodium falciparum infections: is there a risk of over-diagnosis? Swarthout TD, Counihan H, Senga RK, van den Broek I, Malar J 2007 6 58 10.1186/1475-2875-6-58 17506881 (Pubitemid 46902987)
105. Accuracy of rapid tests for malaria and treatment outcomes for malaria and non-malaria cases among under-five children in rural Ghana. Baiden F, Webster J, Tivura M, Delimini R, Berko Y, Amenga-Etego S, Agyeman-Budu A, Karikari AB, Bruce J, Owusu-Agyei S, Chandramohan D, PLoS One 2012 7 34073 10.1371/journal.pone.0034073 22514617
106. Persistence of Plasmodium falciparum HRP-2 in successfully treated acute falciparum malaria. Mayxay M, Pukrittayakamee S, Chotivanich K, Looareesuwan S, White NJ, Trans R Soc Trop Med Hyg 2001 95 179 182 10.1016/S0035-9203(01)90156-7 11355555 (Pubitemid 34947382)
107. WHO, Global Health Expenditure Database Geneva,Switzerland: World Health Organization 2011
108. Impact of integrated community case management on health-seeking behavior in rural Zambia. Seidenberg PD, Hamer DH, Iyer H, Pilingana P, Siazeele K, Hamainza B, MacLeod WB, Yeboah-Antwi K, Am J Trop Med Hyg 2012 87 105 110 10.4269/ajtmh.2012.11-0799 23136285